We are live on ! Find out more

SCMP

Sucampo Pharmaceuticals, Inc.

SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

69 hedge funds and large institutions have $64.9M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New

Increased

Maintained

Reduced

Closed

4% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 25

3% less funds holding

Funds holding: 71 → 69 (-2)

9% less capital invested

Capital invested by funds: $71.3M → $64.9M (-$6.33M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders

Holders Change

-2

Holders Change %

-2.82%

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	GIM Granahan Investment Management Waltham, Massachusetts	+$885K
2	Millennium Management New York	+$391K
3	MC Menta Capital San Francisco, California	+$286K
4	Northern Trust Chicago, Illinois	+$210K
5	PPA Parametric Portfolio Associates Seattle, Washington	+$177K

Top Sellers

Rank	Fund	Capital Flow
1	TC TFS Capital West Chester, Pennsylvania	-$1.17M
2	PAMU Pictet Asset Management (UK) London, United Kingdom	-$671K
3	BIT BlackRock Institutional Trust San Francisco, California	-$471K
4	AG Algert Global San Francisco, California	-$358K
5	HVC Healthcare Value Capital Woodcliff Lake, New Jersey	-$299K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Citadel Advisors Miami, Florida	$302K	-$127K	-19,169	-29%
27	27 Charles Schwab San Francisco, California	$283K	–	–	–
28	SIM 28 Spark Investment Management New York	$267K	+$114K	+17,200	+72%
29	29 AllianceBernstein Nashville, Tennessee	$227K	–	–	–
30	30 Two Sigma Investments New York	$218K	-$142K	-21,424	-39%
31	31 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$212K	+$1.24K	+186	+0.6%
32	32 ProShare Advisors Bethesda, Maryland	$194K	-$37.5K	-5,642	-16%
33	GC 33 Globeflex Capital San Diego, California	$194K	-$2.1K	-317	-1%
34	34 Invesco Atlanta, Georgia	$184K	-$7.97K	-1,200	-4%
35	PCM 35 Prelude Capital Management New York	$179K	-$55.1K	-8,300	-23%
36	PPA 36 Parametric Portfolio Associates Seattle, Washington	$173K	+$177K	+26,653	New
37	37 DekaBank Deutsche Girozentrale Frankfurt, Germany	$169K	+$3.32K	+500	+2%
38	TA 38 Teachers Advisors New York	$144K	–	–	–
39	39 Two Sigma Advisers New York	$131K	+$26.6K	+4,000	+25%
40	40 Wells Fargo San Francisco, California	$129K	-$272K	-40,930	-67%
41	41 Goldman Sachs New York	$119K	+$24.9K	+3,746	+26%
42	EGA 42 Eagle Global Advisors Houston, Texas	$109K	+$112K	+16,820	New
43	43 Deutsche Bank Frankfurt Am Main Ge, Germany	$101K	+$52.8K	+7,953	+105%
44	44 California Public Employees Retirement System Sacramento, California	$99K	–	–	–
45	45 Swiss National Bank Zurich, Switzerland	$95K	–	–	–
46	46 RhumbLine Advisers Boston, Massachusetts	$94K	–	–	–
47	CS 47 Credit Suisse Zurich, Switzerland	$91K	-$63.5K	-9,557	-40%
48	48 AQR Capital Management Greenwich, Connecticut	$85K	–	–	–
49	49 Tudor Investment Corp Stamford, Connecticut	$83K	+$84.8K	+12,761	New
50	BA 50 BlackRock Advisors Wilmington, Delaware	$79K	–	–	–

SCMP Hedge Fund Activity: Q3 2014 in Review

69 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q3 2014, worth a combined $64.9M — down 8.9% from $71.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SCMP and 4 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 24 added.

The largest buyer was Granahan Investment Management, adding an estimated $885K. The largest seller was TFS Capital, exiting entirely with an estimated $1.17M sold.

69 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q3 2014, down from 71 in Q2 2014.
Funds reported $64.9M of Sucampo Pharmaceuticals, Inc. stock for Q3 2014, down 8.9% quarter-over-quarter.
4 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q3 2014 and 6 closed out, a net change of -2 holders.
The largest Sucampo Pharmaceuticals, Inc. buyer in Q3 2014 was Granahan Investment Management, an estimated $885K added.
The largest Sucampo Pharmaceuticals, Inc. seller in Q3 2014 was TFS Capital, an estimated $1.17M sold.

Based on aggregated 13F filings for Q3 2014.

Sucampo Pharmaceuticals, Inc. SCMP